A vapourized Δ9-tetrahydrocannabinol (Δ9-THC) delivery system part II: Comparison of behavioural effects of pulmonary versus parenteral cannabinoid exposure in rodents
Keywords: Δ9-THC, Δ9-tetrahydrocannabinol; 11-OH-Δ9-THC, 11-hydroxy-Δ9-tetrahydrocannabinol; IP, intraperitoneal; IV, intravenous; MDI, metered dose inhaler; SC, subcutaneousΔ9-Tetrahydrocannabinol (Δ9-THC); Pulmonary administration; Locomotion; Cross-sensitization